Repository of colleges and higher education institutions

Show document
A+ | A- | Help | SLO | ENG

Title:Vpliv covid-19 na respiratorno zdravje oseb z in brez predhodnih pljučnih obolenj: vpogled v terapijo, zdravljenje in težave : diplomsko delo visokošolskega strokovnega študijskega programa prve bolonjske stopnje Zdravstvena nega
Authors:ID Gavez, Tilen (Author)
ID Salkunič, Šefik (Mentor) More about this mentor... New window
Files:.pdf DIP_Gavez_Tilen_2025.pdf (3,00 MB)
MD5: C85BEDF326FB4008EBE182AE14A0946E
 
Language:Slovenian
Work type:Bachelor thesis/paper
Typology:2.11 - Undergraduate Thesis
Organization:UAMEU - Alma Mater Europaea University
Abstract:Uvod: Okužba s COVID-19 lahko pusti dolgotrajne posledice na respiratornem zdravju, še posebej pri osebah s predhodnimi pljučnimi obolenji, kot sta astma in kronična obstruktivna pljučna bolezen (KOPB). Razumevanje učinkov različnih terapevtskih pristopov in njihove učinkovitosti je ključno za boljše obvladovanje posledic bolezni. Metodologija: Izvedena je bila retrospektivna kvantitativna analiza zdravstvene dokumentacije 126 pacientov, zdravljenih zaradi COVID-19 v Zdravstvenem domu dr. Adolfa Drolca Maribor. Podatki so bili obdelani z deskriptivnimi metodami, hi-kvadrat testom in logistično regresijo za ugotavljanje povezav med terapevtskimi pristopi in dolgotrajnimi respiratornimi težavami. Rezultati: Raziskava je pokazala, da ima vrsta uporabljene terapije statistično značilen vpliv na verjetnost pojava dolgotrajnih težav po COVID-19. Kombinacija glukokortikoidov in bronhodilatatorjev se je izkazala kot najučinkovitejša, predvsem pri hujših primerih. Spol ni bil pomemben dejavnik, medtem ko so imeli bolniki s predhodnimi pljučnimi obolenji več težav, a razlika ni bila statistično značilna. Diskusija in zaključek: Prilagajanje terapije glede na začetno zdravstveno stanje posameznika je ključnega pomena za izboljšanje izidov zdravljenja. Potrebno je tudi dolgoročno spremljanje bolnikov in večja pozornost, namenjena obvladovanju respiratornih posledic okužbe s COVID-19 v klinični praksi.
Keywords:COVID-19, respiratorno zdravje, kronične bolezni, terapija, bronhodilatator, pljučna funkcija
Place of publishing:Maribor
Place of performance:Maribor
Publisher:T. Gavez
Year of publishing:2025
Year of performance:2025
Number of pages:39 str.
PID:20.500.12556/ReVIS-12196 New window
COBISS.SI-ID:249144579 New window
UDC:616.98:578.834(043.2)
Publication date in ReVIS:16.09.2025
Views:173
Downloads:13
Metadata:XML DC-XML DC-RDF
:
Copy citation
  
Share:Bookmark and Share


Hover the mouse pointer over a document title to show the abstract or click on the title to get all document metadata.

Secondary language

Language:English
Abstract:Introduction: COVID-19 infection can leave long term consequences on respiratory health, especially in individuals with pre-existing pulmonary conditions such as asthma and chronic obstructive pulmonary disease (COPD). Understanding the effects of different therapeutic approaches and their effectiveness is crucial for better management of the disease aftermath. Methodology: A retrospective quantitative analysis was conducted on the medical records of 126 patients treated for COVID-19 at the Health Center dr. Adolf Drolc in Maribor. The data was processed using descriptive methods, the chi-square test and logistic regression to determine associations between therapeutic approaches and long- Results: The study showed that the type of therapy used had a statistically significant impact on the likelihood of developing long term complications after the COVID-19. The combination of glucocorticoids and bronchodilators proved to be the most effective, especially in more severe cases. Gender was not a significant factor, whereas patients with pre-existing pulmonary conditions experienced more complications, although the difference was not statistically significant. Discussion and conclusion: Tailoring therapy based on the patient’s initial health status is essential for improving treatment outcomes. Long term monitoring of patients is also necessary, along with increased attention to managing the respiratory consequences of COVID-19 in clinical practice.
Keywords:COVID-19, respiratory health, chronic diseases, therapy, bronchodilator, lung function, nursing care


Back